Dr. Burton L. Scott
Dr. Burton L. Scott, MD, PhD, Professor of Neurology at Duke University is a member of the Duke Movement Disorders Clinic. After the completion of his residency at Duke University and fellowship training in movement disorders at Baylor College of Medicine, he joined the Duke faculty in 1995. Over his career, he has been very active in the care of HD patients and their families. He was instrumental in creating an opportunity to obtain Tetrabenazine for HD patients as the Principal Investigator of the clinical study “Compassionate Use of Tetrabenazine in Hyperkinetic Movement Disorders”. He has many years of experience in the use of this complicated drug, currently one of two FDA approved drugs for the treatment of the chorea associated with Huntington’s Disease. He has been very active in Parkinson’s Disease research and clinical care over his career. Recently, he has chosen to expand his work with HD patients and families and recruited many professionals to work in a dedicated Huntington’s Disease clinic.
